Risk factors for PE (provoked vs. unprovoked, trigger(s) if provoked)
Risk stratification (non-massive, submassive, massive)
Initial vs. recurrent episode
PE-CT results
LENI results, if relevant
Initial anticoagulation
Hypercoagulability workup, if relevant
Review of age-appropriate cancer screening, what needs to be done at discharge
IVC filter, if relevant (date placed, recommended date of removal if removable)
Consultants involved
Type and duration of anticoagulation on discharge (bridge to warfarin, if needed)
Possible warfarin drug-drug interactions
Last three INRs and dates, if going to SNF/LTAC on warfarin
Cr and GFR on discharge, if using novel anticoagulant
Plan for follow-up (tests pending at time of discharge (eg. hypercoagulability panel), outpatient follow-up, who will follow INR if on warfarin (AMS or other), labs needed after discharge and who will follow them up)